Dominik Mertz
-
- Antibiotic Use and Resistance 14
- Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus 16
- Clostridium difficile and Clostridium perfringens research 14
- Epidemiology top 2%
- Respiratory viral infections research 12
- Influenza Virus Research Studies 9
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing 14
-
- Nosocomial Infections in ICU 11
-
- Streptococcal Infections and Treatments 10
- Co-authors
- Mark LoebCarson K. L. LoJoshua Z. GoldenbergBradley C. JohnstonLyubov LytvynCalvin Ka-Fung LoUrsula FlückigerJennifer Beardsley
- Journals
- JAMA (1 paper)SHILAP Revista de lepidopterología (2 papers)Gastroenterology (1 paper)
- Partner nations
- CanadaSwitzerlandUnited States
In The Last Decade
Dominik Mertz
110 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Applied Microbiology and Biotechnology 397
- Infectious Diseases 1.4k
- Epidemiology 1.6k
- Clinical Biochemistry 293
- Critical Care and Intensive Care Medicine 188
Countries citing papers authored by Dominik Mertz
This map shows the geographic impact of Dominik Mertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominik Mertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominik Mertz more than expected).
Fields of papers citing papers by Dominik Mertz
This network shows the impact of papers produced by Dominik Mertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominik Mertz. The network helps show where Dominik Mertz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dominik Mertz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 11 | |
| 9 | 2021 | 35 | |
| 10 | 2021 | 13 | |
| 11 | 2020 | 20 | |
| 12 | 2020 | 23 | |
| 13 | 2020 | 59 | |
| 14 | 2019 | 4 | |
| 15 | 2018 | 4 | |
| 16 | 2017 | 7 | |
| 17 | 2017 | 66 | |
| 18 | Does Extending Clostridium Difficile Treatment In Patients Who Are Receiving Concomitant Antibiotics Reduce The Rate Of Relapse | 2016 | 9 |
| 19 | 2015 | 21 | |
| 20 | 2010 | 42 |
About Dominik Mertz
Dominik Mertz is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Critical Care and Intensive Care Medicine, having authored 120 papers that have together received 5.0k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (16 papers), Antibiotic Use and Resistance (14 papers), Bacterial Identification and Susceptibility Testing (14 papers), Clostridium difficile and Clostridium perfringens research (14 papers), Respiratory viral infections research (12 papers), Nosocomial Infections in ICU (11 papers), Streptococcal Infections and Treatments (10 papers) and Influenza Virus Research Studies (9 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (397 citations), Infectious Diseases (1.4k citations) and Epidemiology (1.6k citations). Dominik Mertz has collaborated with scholars based in Canada, Switzerland and United States. Frequent co-authors include Mark Loeb, Carson K. L. Lo, Joshua Z. Goldenberg, Bradley C. Johnston, Lyubov Lytvyn, Calvin Ka-Fung Lo, Ursula Flückiger, Jennifer Beardsley, Jennie Johnstone and Dat Tran. Their work appears in journals such as JAMA, SHILAP Revista de lepidopterología and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.